MARKET

VERA

VERA

Vera Therapeutics, Inc.
NASDAQ
20.29
-0.95
-4.47%
Opening 13:31 05/21 EDT
OPEN
20.85
PREV CLOSE
21.24
HIGH
21.01
LOW
20.23
VOLUME
255.24K
TURNOVER
--
52 WEEK HIGH
51.61
52 WEEK LOW
18.53
MARKET CAP
1.29B
P/E (TTM)
-6.7798
1D
5D
1M
3M
1Y
5Y
1D
Notable Tuesday Option Activity: LRCX, BURL, VERA
NASDAQ · 22h ago
Vera Therapeutics Holds 2025 Annual Stockholder Meeting
TipRanks · 1d ago
Weekly Report: what happened at VERA last week (0512-0516)?
Weekly Report · 2d ago
Vera Therapeutics: Huge Catalyst Upcoming For Kidney Disease Drug
Seeking Alpha · 5d ago
Weekly Report: what happened at VERA last week (0505-0509)?
Weekly Report · 05/12 11:58
Evercore ISI Remains a Buy on Vera Therapeutics (VERA)
TipRanks · 05/08 06:58
Vera Therapeutics: Strategic Advancements and Strong Financial Position Underpin Buy Rating
TipRanks · 05/07 19:35
Vera Therapeutics Price Target Cut to $26.00/Share From $34.00 by Wedbush
Dow Jones · 05/07 16:08
More
About VERA
Vera Therapeutics, Inc. is a late-stage biotechnology company. The Company is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B-cell Activating Factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgAN, also known as Berger’s disease, and lupus nephritis. In addition, it is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful. It is also engaged in developing MAU868, a monoclonal antibody designed to neutralize infection with BK virus (BKV), a polyomavirus that can have devastating consequences in certain settings such as kidney transplant. It retains all global developmental and commercial rights to atacicept and MAU868.

Webull offers Vera Therapeutics Inc stock information, including NASDAQ: VERA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VERA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VERA stock methods without spending real money on the virtual paper trading platform.